RxDoctor Payments Data

Briana Rauch, NP

Family · Fremont, OHNPI 1184021362

Payments from drug & device makers

$1,962in general payments, 2019–2025

Across 110 payments — averaging $17.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$468
  • Novo Nordisk$233
  • Teva Pharmaceuticals USA, Inc.$208
  • Otsuka America Pharmaceutical, Inc.$162
  • Novartis$140
  • Bayer$132
  • plus $620 from 18 others

What the payments were for

  • Food & beverage$1,962100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,962 in reported general payments places this provider in the 80th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$19,636
Medicare patients
96
Services billed
303

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TrulicityDulaglutide20$34,366
JardianceEmpagliflozin19$29,849
OzempicSemaglutide15$24,510
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog11$4,317
Celecoxib16$675
Atorvastatin Calcium71$513
Duloxetine Hcl20$367
Metformin Hcl28$325
Lisinopril49$323
Rosuvastatin Calcium28$298
Losartan Potassium33$263
Levothyroxine Sodium35$225
Carvedilol17$218
Omeprazole19$208
Alendronate Sodium27$185

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Lilly USA, LLCTrulicity$31$34,36620 claims
Novo NordiskOzempic$233$24,51015 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 6,812 family providers in Ohio.

Other family in Fremont

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →